Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C

Título:

Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C

Autor:

Sabrina Calil-Elias

Ano:

2019

DOI:

10.1002/pds.4904

Revista:

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

ISSN:

10538569

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

PHARMACEUTICAL HOME MONITORING FOR ONCOLOGY PATIENTS IN PALLIATIVE CARE

Análise da informação sobre cloroquina e ivermectina nas mídias digitais Youtube e Instagram: relação entre Covid-19 e infodemia

Myotoxicity induced by a acidic ASP-49 phospholipase A2 isolated from Lachesis muta snake venom is mimicked by lysophosphatidylcholine

Analgesic drugs: What quality of information is present on the Internet?

Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane

Calcium distribution on muscular fibers exposed to Bothrops jararacussu venom

In Vivo and In Vitro Taste Assessment of Artesunate-Mefloquine, Praziquantel, and Benznidazole Drugs for Neglected Tropical Diseases and Pediatric Patients

Ferramenta para acompanhamento farmacoterapêutico de pacientes críticos

Occurrence of sulfated fucose branches in fucosylated chondroitin sulfate are essential for the polysaccharide effect preventing muscle damage induced by toxins and crude venom from Bothrops jararacussu snake

Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin.